Filing Details
- Accession Number:
- 0001209191-15-038441
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-04 16:30:33
- Reporting Period:
- 2015-04-30
- Filing Date:
- 2015-05-04
- Accepted Time:
- 2015-05-04 16:30:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1267602 | Alimera Sciences Inc | ALIM | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1489533 | Daniel C. Myers | 6120 Windward Parkway, Suite 290 Alpharetta GA 30005 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-04-30 | 663 | $3.79 | 90,980 | No | 5 | A | Direct | |
Common Stock | Disposition | 2015-05-01 | 2,000 | $4.37 | 88,980 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- These shares were acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d).
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2014.